biomanufacturing market

biomanufacturing market

featured image of Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70

Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70

BIOT

🤖 Vendor-agnostic automation system for cell and gene therapy manufacturing reduces errors and lowers costs.💡

featured image of Revolutionary Ribosome Engineering: Lowering Drug Costs and Fueling the Bioeconomy

Revolutionary Ribosome Engineering: Lowering Drug Costs and Fueling the Bioeconomy

BIOT

💡 Ribosome pool engineering 💊🌱🧬 can transform the bioeconomy by increasing protein synthesis yields and lowering drug manufacturing costs. 🔬🚀

featured image of Revolutionizing Cell Therapy Manufacturing: Faster & Safer

Revolutionizing Cell Therapy Manufacturing: Faster & Safer

BIOT

🔎 This article explores the challenges in cell therapy manufacturing and the urgency for faster processes. It discusses closed-process systems, bioreactors, and rapid testing methods to improve efficiency. It emphasizes the significance of streamlined manufacturing and quality control testing for faster treatment delivery. The need for a common manufacturing platform and scalability in cell therapy production is also addressed.

featured image of University of Delaware's Groundbreaking Biomanufacturing Hub Boosts Economic Growth and Innovation

University of Delaware’s Groundbreaking Biomanufacturing Hub Boosts Economic Growth and Innovation

BIOT

🏗️ The University of Delaware breaks ground on the SABRE Center, a biomanufacturing facility, to boost economic growth in biopharmaceuticals. 💼💰💡🌍🏭💪

featured image of Merck Revolutionizes Biosafety Testing with Game-Changing Genetic Stability Assay

Merck Revolutionizes Biosafety Testing with Game-Changing Genetic Stability Assay

BIOT

Merck introduces a game-changing genetic stability assay for biosafety testing, simplifying and reducing time and costs. 🧬💼

featured image of Fujifilm Invests $12B to Create Massive Biopharmaceutical Facility in North Carolina

Fujifilm Invests $12B to Create Massive Biopharmaceutical Facility in North Carolina

BIOT

📢 Fujifilm invests $1.2B to expand North Carolina CDMO, adding 8 bioreactors and becoming a top biopharmaceutical facility. 🏭💰💼🌍

featured image of Ascend Acquires GMP Facility Boosts Gene Therapy

Ascend Acquires GMP Facility Boosts Gene Therapy

BIOT

📢 Ascend Advanced Therapies secures Beacon Therapeutics' GMP facility in Florida, boosting gene therapy expertise and product supply. 🔬🤝👁️

featured image of Lonza Partners with Acumen for Alzheimer's Breakthrough

Lonza Partners with Acumen for Alzheimer’s Breakthrough

BIOT

📰 Lonza teams up with Acumen to make sabirnetug, a groundbreaking Alzheimer's therapy, at their New Hampshire facility. 👥 🧪 Sabirnetug targets toxic amyloid beta oligomers, offering hope in the fight against Alzheimer's. 💡 ⏩ Exciting collaboration to speed up Alzheimer's treatment development. Lonza Acumen AlzheimersTherapy Sabirnetug

featured image of Boost mRNA Manufacturing with Digital Optimization

Boost mRNA Manufacturing with Digital Optimization

BIOT

📰 Researchers in Germany developed a digital model to optimize mRNA manufacturing, resulting in increased production and reduced truncation. 💻💉

featured image of FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!

FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!

BIOT

📢 The FDA published new guidance for CAR-T cell products, covering change management, risk assessment, flow cytometry, and more. 👩‍🔬🔬🧪🗂 CAR-T FDA